Cardio Diagnostics Holdings, Inc. (CDIO) vs Enveric Biosciences, Inc. (ENVB)
A side-by-side comparison of Cardio Diagnostics Holdings, Inc. and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDIO
Cardio Diagnostics Holdings, Inc.
$2.05HealthcareDelayed quote: Oct 6, 2026, 10:18 AM EDT
ENVB
Enveric Biosciences, Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 10:27 AM EDT
Total return — CDIO vs ENVB
growth of $100 · dividends reinvested · last 4yCDIO -99.4% (-71.8%/yr)ENVB -99.9% (-83.5%/yr)CDIO compounded faster over this window
Log scale — wide-divergence pair
CDIO ENVB
CDIO vs ENVB: by the numbers
- •ENVB is the larger company ($7M vs $6M market cap).
- •Both run net losses; ENVB's is the smaller (0.00% vs -44771.83% net margin).
Metrics side by side
Valuation
| Metric | CDIO | ENVB |
|---|---|---|
| P/S ratio | 419.86 | N/A |
| P/B ratio | 0.82 | 0.81 |
Profitability
| Metric | CDIO | ENVB |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -43737.46% | 0.00% |
| Net margin | -44771.83% | 0.00% |
| ROE | -87.12% | -108.00% |
| ROIC | -82.84% | -107.99% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.